elabscience covid-19

Research Solutions for Coronavirus – Elabscience

Contact us
Place an Order
Product Brochure

Ready-to-Use COVID-19 IgG/IgM Rapid Test Kit

COVID-19 IgG/IgM Rapid Test Kit

For suspicious patients with symptoms, mild symptoms, or even without symptoms

 

COVID-19(Corona Virus Disease) is an infectious disease caused by the most recently discovered coronavirus. This highly contagious new virus and disease were unknown before the outbreak began in Wuhan, China which spread all over the world very quickly. COVID 19 IgG/IgM Rapid Test (Whole Blood/ Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to COVID 19 in human whole blood, serum or plasma as an aid in the diagnosis of primary and secondary COVID 19 infections.

Product Information

Catalog No.: UNCOV-40
Principle: GICA
Specimen: Human Serum, Plasma or Whole Blood
Format: Cassette
Reading Time: 10 minutes
Package: 40T/kit
Reagents : Test Cassette, Buffer, Dropper, Desiccant.

Product Advantages

Easier: No special equipment needed, Intuitive visual interpretation.

Rapid: Quick sampling by fingertip blood, Result in 10 15min.

Accurate: Results with IgG and IgM respectively, validated using PCR and CT.

Application: For suspicious patients with symptoms, mild symptoms, or even without
symptoms, also for testing people with close contact of infected patients and people under
quarantine control.

Product Performances

Sensitivity: 98.81% (95% CI: 97.25%, 99.61%)

Specificity: 98.02% (95% CI: 97.05%, 98.74%)

Test Procedures

1. Sample collection and preparation.

2. Keep the kit and sample to room temperature prior to testing.

3. Add sample to the sample well using a micropipette.

4. Add buffer to the sample well.

5. Wait for the colored line(s) to appear and read the result at 10 minutes .

Interpretations of Results

IgM Positive: indicated of primary COVID 19 infection.

IgG and IgM Positive: indicated of secondary COVID 19 infection.

IgG Positive: indicated of past COVID 19 infection.

Negative: indicated of no previous infection.

Invalid: indicating that the experiment is failed.

Other Products*

*for research use only

Elab E-HD-C044 Human Corona Virus Disease 2019 (COVID-19) IgG/IgM Lateral Flow Assay Kit (Whole Blood/ Serum/ Plasma) RUO Antibody based Test kit   40 tests

Raw Material for COVID-19 IVD Rapid Test Development

Raw materials for IVD

With the now global outbreak of COVID-19, a fast, convenient and specific method for in vitro diagnosis of COVID-19 infection is urgent for fighting and preventing this disease. Elabscience® is not only providing the SARS-CoV-2 (2019-nCoV) IgG/IgM Lateral Flow Assay Kit for SARS-CoV-2 research, but also providing raw materials for development of COVID-19 IgG/IgM Rapid Test in IVD use.

Advantages

  • High specificity
  • Bulk in stock
  • Fast for use
  • Cost-effective

COVID-19 IgG/IgM Rapid Test Development Kit

This kit contains essential reagents for the development of COVID-19 IgG/IgM Lateral Flow (Rapid Test) assay to help with the qualitative detection of IgG and IgM antibodies specific to SARS-CoV-2 in human biological fluids.

View more details about raw materials for COVID-19 IV

Raw Materials for COVID-19 IgG/IgM Rapid Test Kit

The raw materials including the most important reagents, antigen and antibodies, can be also available separately.

Cat. No. Product Name Size
E-ELC-001 Recombinant SARS-CoV-2 N Protein (His Tag) 1/5/10 mg
E-ELC-002 Recombinant SARS-CoV-2 N Protein (with colloidal gold conjugated) 1/5/10 mL
E-ELC-003 Mouse anti-human IgG monoclonal 1/5/10 mg
E-ELC-004 Mouse anti-human IgM monoclonal 1/5/10 mg
E-ELC-005 Goat anti-chicken IgY polyclonal 1/5/10 mg
E-ELC-006 Chicken IgY(with colloidal gold conjugated) 1/5/10 mL
E-ELC-008 Buffer for Rapid Test Development(02) 1000/5000/10000 Tests

With the now global outbreak of COVID-19, SARS-CoV-2 early diagnostics and infection prevention and control has become critical. Elabscience® can also provide the following antibodies for SARS-CoV-2 (2019-nCoV, COVID-19 virus) research:

Proteinase K

Proteinase K
Proteinase K is a kind of high activity proteinase of subtilisin, which is used to degrade proteins in biological samples. It can be used to digest various proteins, and it can be used in a variety of molecular biology, cell biology and other related experiments, such as genomic DNA extraction, enzyme digestion and removal, cell permeability and so on.
Proteinase K is mainly used for the production of nucleic acid extraction kit, especially for nucleic acid extraction from samples of nucleic acid diagnosis and detection in vitro diagnosis (IVD) industry.

Shortage of supply
Due to the outbreak of “2019-nCOV”, the demand for nucleic acid detection is soaring, and the supply of raw materials for detection reagents is also very tight, including Proteinase K extracted from nucleic acid.

A large wave of Proteinase K is coming!
In order to alleviate the supply pressure of Proteinase K and provide sufficient raw material support for the detection of new coronavirus, our R&D team with strong strength of Elabscience® has solved the problems of batch production time, product quality and yield in a short time by using the international leading protein purification platform.

Brand Elabscience®
Product Proteinase K Lyophilized Powder
Cat.No. E-IR-R109U
Nature Recombination
Valid Period 2~8°C for two years. RT for one year.
Purity ≥95% by SDS-PAGE
Application Genomic DNA Purification Kit, RNA Purification Kit, Gene Diagnostic Kit, IHC, ISH and other possible application.
Activity ≥30 U/mg
Capacity 15~20 kg/Month

Product characteristics

  • Recombinant expression in yeast
  • Activity ≥30 U/mg
  • DNase and RNase free
  • Recommend usage 50~200 μg/mL

Activity result
Elabscience® standard production process requires that the activity ratio ≥30 U/mg. In fact, the activity ratio exceeded the expected production standard, content the application requirements of customers.
Unit definition: One unit is defined as the amount of enzyme that catalyzes the formation of 1 μmol of tyrosine per minute at pH 7.5 at 37°C.

Calibration curve
According to the absorbance A275 for the vertical axis, the different concentrations of tyrosine as the horizontal axis, the standard curve was drawn.

Detection of DNase and RNase residues
Use DNase and RNase detection kit to detect the DNase and RNase residues with different Lots of Proteinase K. The results showed that there were no DNase nor RNase in Proteinase K.

Neutralization Test Kits

Code  Name  Test type  Size 
CP04010-25 Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Colloidal gold Immunoassay) Lateral Flow Assay 25T
CP04011-25 Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Immunofluorescence Assay) Lateral Flow Assay 25T
CP04012 Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Enzyme-linked immunosorbent assay) ELISA 96T/480T

SARS-COV-2 Neutralization Antibodies ELISA kits

Cat # Product Name
E-EL-E606 SARS-CoV-2 Neutralization Antibody ELISA Kit
E-EL-E608 SARS-CoV-2 Neutralization Antibody ELISA Kit
Semi-Quantitative Assay

SARS-COV-2 Antibodies ELISA kits

Cat # Product Name
E-EL-E600 SARS-CoV-2 Nucleocapsid Protein IgG ELISA Kit
E-EL-E601 SARS-CoV-2 Nucleocapsid Protein IgM ELISA Kit

SARS-Cov-2 Related Cell Lines

Cat # Product Name
EP-CL-0491 VERO C1008 [Vero E6] cell line
EP-CL-0242 Vero Cell Line
EP-CL-0054 Calu-3 Cell Line
EP-CL-0120 HuH-7 Cell Line
EP-CL-0050 Caco-2 Cell Line  
EP-CL-0005 293T [HEK-293T] Cell Line  
EP-CL-0141 LLC-MK2 cell line  

SARS-CoV-2 Variant Proteins

Omicron (B.1.1.529/South Africa*)

The Omicron variant is by far the most divergent variant characterized by a high number of mutations in the spike protein. Several mutations (e.g., N501Y, P681H) have been identified in previous variants and are associated with increased transmissibility, immune escape, or other properties.

Cat.No. Protein Mutation Tags
PKSV030470 Nucleocapsid P13L, E31del, R32del, S33del, R203K, G204R N-His Tag
PKSV030471 S1+S2 A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F ECD, C-His Tag
PKSV030473 Spike S1 NTD A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I ECD, C-His
PKSV030474 Spike RBD G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H mFc Tag
PKSV030475 Spike RBD G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H N-His Tag
PKSV030476 Spike RBD G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H C-hFc Tag
PKSV030477 Spike RBD G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H C-His Tag
PKSV030478 S1+S2 trimer A67V, H69del, V70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K and L981F C-His Tag
PKSV030479 Spike RBD G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H C-6His-Avi
PKSV030480 Spike S1 A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H C-His Tag

Delta/Kappa (B.1.617/India*)

The rapid escalation of the epidemic in India caught people off guard. Compared with the rebound of the epidemic in other countries, the epidemic in India swept across the country at a faster speed.

Scientists believe that a new variant B. 1617 with a double mutation may be responsible for the recent surge in cases in India.

Cat.No. Protein Mutation Tags
PKSV030334 RBD L452R C-His
PKSV030335 RBD E484Q C-His
PKSV030336 RBD L452R，E484Q C-His
PKSV030337 N D377Y N-His
PKSV030338 S1 D614G, E154K, E484Q, L452R, P681R C-His

Gamma (P.1/Brazil*)

It has spread in Japan, United States, Brazil and Germany, and there is no evidence of increased transmission and pathogenicity. Three characteristic mutations, K417N, E484K and N501Y were found in RBD region. Due to the presence of E484K in RBD region, scientists are worried that it may have immune escape.

Cat.No. Protein Mutation Tags
PKSV030317 RBD E484K, K417T, N501Y C-His
PKSV030373 N P80R N-His
PKSV030374 S1+S2 ECD L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F C-His
PKSV030375 S1+S2 ECD L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I C-His
PKSV030376 S1 L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y C-His
PKSV030377 S1 T20N, D614G C-His
PKSV030378 RBD K417T, E484K, N501Y C-His
PKSV030379 RBD K417T, E484K, N501Y C-rFc
PKSV030380 RBD K417T C-rFc

Beta (B.1.351/South Africa*)

The study shows that the transmission capacity of the disease increases by about 50%, but there is no evidence to prove the increase of pathogenicity. E484k is found in RBD region, which is considered to be the main reason for the decrease of neutralization activity of neutralization antibody.

Cat.No. Protein Mutation Tags
PKSV030319 RBD K417N,E484K,N501Y C-His
PKSV030357 S1+S2 ECD D80A, ΔLAL242-244, R246I, K417N, E484K, N501Y, D614G, A701V C-His
PKSV030358 S1+S2 ECD L18F, D80A, D215G, ΔLAL242-244, R246I, K417N, E484K, N501Y, D614G, A701V C-His
PKSV030359 S1+S2-Biotinylated L18F, D80A, D215G, ΔLAL242-244, R246I, K417N, E484K, N501Y, D614G, A701V C-His
PKSV030360 S1+S2 ECD D80A, K417N, E484K, N501Y, D614G, A701V C-His
PKSV030361 S1 K417N, E484K, N501Y, D614G C-His
PKSV030362 S1 NTD L18F, D80A, D215G, ΔLAL242-244, R246 C-His
PKSV030363 S1 L18F, D80A, D215G, ΔLAL242-244, R246I, K417N, E484K, N501Y, D614G C-His
PKSV030364 RBD K417N C-His
PKSV030365 RBD-Biotinylated K417N C-His
PKSV030366 RBD E484K C-His
PKSV030367 RBD-Biotinylated E484K C-His
PKSV030368 RBD K417N, E484K, N501Y C-His
PKSV030369 RBD-Biotinylated K417N, E484K, N501Y C-His
PKSV030370 RBD E484K C-rFc
PKSV030371 RBD K417N, E484K, N501Y C-rFc
PKSV030372 RBD K417N C-rFc

Epsilon (B.1.429/B.1.427/California*)

Also known as CAL.20C, researchers at cedars Sinai Medical Center first observed it in California in July 2020. Recently, it has appeared in other countries, such as Australia. The mutation may be more transmissible, and the data show that it accounts for most of the cases isolated in California. Its characteristic mutation includes L452R, which can reduce the sensitivity to neutralizing antibody. More studies are needed on this mutation.

Cat.No. Protein Mutation Tags
PKSV030339 S1 W152C, L452R, D614G C-His
PKSV030340 N T205I N-His

Alpha (B.1.1.7/ United Kingdom*)

It was found in the UK first, and the research shows that its communication power has increased by more than 30%. Davies team modeled the data from three regions of the UK and estimated that the transmissibility of the mutant was 56% higher than that of the previous mutants. There were 10 characteristic mutations in Spike and 2 characteristic mutations in NP.Since spike protein is the main target of vaccine development and therapeutic antibody development, whether these mutations will produce antibody escape and reduce the efficacy of vaccines and antibody drugs has become the focus of scientists.

Cat.No. Protein Mutation Tags
PKSV030318 RBD N501Y C-His
PKSV030341 N R203K, G204R N-His
PKSV030342 N E378Q N-His
PKSV030343 N I292T N-His
PKSV030344 N D3L, R203K, G204R, S235F N-His
PKSV030345 N D3L, S235F N-His
PKSV030346 S1+S2 ECD ΔHV69-70,ΔY144,N501Y,A570D,D614G,P681H,T716I,S982A,D1118H C-His
PKSV030347 S1 ΔHV69-70, ΔY144, N501Y, A570D, D614G, P681H C-His
PKSV030348 S1-Biotinylated ΔHV69-70, ΔY144, N501Y, A570D, D614G, P681H C-His
PKSV030349 S1 ΔHV69-70,N501Y,D614G C-His
PKSV030350 RBD N501Y C-hFc
PKSV030351 RBD S494P C-His
PKSV030352 RBD N501Y C-His
PKSV030353 RBD-Biotinylated N501Y C-His
PKSV030354 RBD N501Y C-rFc
PKSV030355 N S194L N-His
PKSV030356 N P13L N-His

Mink Variant (Denmark*)

Scientists have found that a SARS-CoV-2 mutant form in Denmark which was previously found in minks. This mutant virus appears to have spread from animals to humans in Denmark. Experts said that the virus invade different biological systems will lead to different types of mutation, once the virus passed from animals to people, it is easy to have problems, this mutation may threaten the effectiveness of any vaccine in the future.

Cat.No. Protein Mutation Tags
PKSV030381 S1 ΔH69/ΔV70, Y453F, D614G C-His
PKSV030382 RBD Y453F C-His
PKSV030383 RBD Y453F C-rFc

Mutation of Nucleocapsid

It has spread in Japan, United States, Brazil and Germany, and there is no evidence of increased transmission and pathogenicity. Three characteristic mutations, K417N, E484K and N501Y were found in RBD region. Due to the presence of E484K in RBD region, scientists are worried that it may have immune escape.

 

Cat.No. Protein Mutation Tags
PKSV030337 N D377Y N-His
PKSV030340 N T205I N-His
PKSV030341 N R203K, G204R N-His
PKSV030342 N E378Q N-His
PKSV030343 N I292T N-His
PKSV030344 N D3L, R203K, G204R, S235F N-His
PKSV030345 N D3L, S235F N-His
PKSV030355 N S194L N-His
PKSV030356 N P13L N-His
PKSV030373 N P80R N-His

More Variants

Cat.No. Protein Mutation Tags
PKSV030287 S-trimer R751S C-6His
PKSV030320 RBD E484K C-His
PKSV030321 RBD L452R C-His
PKSV030384 RBD-SD1 N354D, D364Y C-6His
PKSV030385 RBD-SD1 W436R C-6His
PKSV030386 RBD-SD1 V367F C-6His
PKSV030387 S1 D614G C-10His
PKSV030388 S-trimer D614G C-6His
PKSV030389 S-trimer D614G, N439K C-6His
PKSV030390 S-trimer Y453F,D614G C-6His
PKSV030391 S-trimer ΔFVI C-6His
PKSV030392 S1+S2 ECD D614G C-His
PKSV030393 S1+S2 ECD ΔHV69-70, D614G, D796H C-His
PKSV030394 S2 E780Q C-hFc
PKSV030395 S1 D614G C-hFc
PKSV030396 S1 N234Q C-His
PKSV030397 S1 Q677H C-His
PKSV030398 S1 A222V, D614G C-His
PKSV030399 S1 L18F, D614G C-His
PKSV030400 S1 ΔHV69-70, N439K, D614G C-His
PKSV030401 RBD V367F C-mFc
PKSV030402 RBD F342L C-6His
PKSV030403 RBD N354D C-6His
PKSV030404 RBD V367F C-6His
PKSV030405 RBD R408I C-6His
PKSV030406 RBD A435S C-6His
PKSV030407 RBD K458R C-6His
PKSV030408 RBD G476S C-6His
PKSV030409 RBD V483A C-6His
PKSV030410 RBD D364Y C-6His

 

Cat.No. Protein Mutation Tags
PKSV030411 RBD V341I C-6His
PKSV030412 RBD N439K C-6His
PKSV030413 RBD Y508H C-His
PKSV030414 RBD V503F C-His
PKSV030415 RBD A522V C-His
PKSV030416 RBD A372S C-His
PKSV030417 RBD A520S C-His
PKSV030418 RBD A522S C-His
PKSV030419 RBD D405V, Q414A C-His
PKSV030420 RBD Q414E C-His
PKSV030421 RBD P384L C-His
PKSV030422 RBD A348S C-His
PKSV030423 RBD F338L C-His
PKSV030424 RBD F377L C-His
PKSV030425 RBD P521S C-His
PKSV030426 RBD T478I C-His
PKSV030427 RBD V483I C-His
PKSV030428 RBD S359N C-His
PKSV030429 RBD K378R C-His
PKSV030430 RBD Q409E C-His
PKSV030431 RBD I472V C-His
PKSV030432 RBD A372T C-His
PKSV030433 RBD A344S C-His
PKSV030434 RBD A520V C-His
PKSV030435 RBD E406Q C-His
PKSV030436 RBD F490S C-His
PKSV030437 RBD K378N C-His
PKSV030438 RBD N370S C-His
PKSV030439 RBD Q414R C-His
PKSV030440 RBD S477I C-His

 

Cat.No. Protein Mutation Tags
PKSV030441 RBD S477N C-His
PKSV030442 RBD T385A C-His
PKSV030443 RBD T393P C-His
PKSV030444 RBD V395I C-His
PKSV030445 RBD A475V C-His
PKSV030446 RBD G446V C-His
PKSV030447 RBD G485S C-His
PKSV030448 RBD G482S C-His
PKSV030449 RBD K444R C-His
PKSV030450 RBD N440K C-His
PKSV030451 RBD E471Q C-His
PKSV030452 RBD P479S C-His
PKSV030453 RBD A352S C-His
PKSV030454 RBD P337S C-His
PKSV030455 RBD P521R C-His
PKSV030456 RBD S477R C-His
PKSV030457 RBD L455F C-His
PKSV030458 RBD K458Q C-His
PKSV030459 RBD N481D C-His
PKSV030460 RBD F456L C-His
PKSV030461 RBD Y505C C-His
PKSV030462 RBD F456E C-His
PKSV030463 RBD F486S C-His
PKSV030464 RBD N487R C-His
PKSV030465 RBD G446S C-His
PKSV030466 RBD P499R C-His
PKSV030467 RBD V445F C-His
PKSV030468 RBD F490L C-His
PKSV030469 RBD W436R C-His

*Country or region: Where the mutant was first found.

SARS-CoV-2 Omicron Peptides Pools

Catalogue # Product Name Size Pool List
S-CP-P2010 SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) 2 Vials (25 µg/ peptide) List of peptides

SARS-CoV/CoV-2 (2019-nCoV) Proteins

Spike Protein

The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor, and S2 contains basic elements needed for the membrane fusion.

Nucleocapsid Protein (N protein)

The coronavirus N protein is abundantly produced within infected cells. N protein has multiple functions, including binding to viral RNA to form the ribonucleocapsid and has also been proposed to have roles in virus replication, transcription and translation.In host cells, N proteins have been shown to cause deregulation of the cell-cycle, inhibit the production of interferon, up-regulate the production of COX2, up-regulate the activity of AP1, and induce apoptosis in serum deprived cells-of all which may have possible pathological consequences.

Membrane and Unstructural Proteins

Membrane protein and Envelope protein are the key to the efficient assembly of coronavirus.
3C-like proteinase of SARS-CoV-2 virus is a key protein in RNA replication.
Papain-like protease (NSP3) plays an important role in the precursor cleavage of various viral proteins to form a series of functional proteins needed in viral replication.
3C-like proteinase and Papain-like protease are important targets for the development of antiviral drugs, which can inhibit virus replication and reduce related mortality.

ACE2 Protein

ACE2 (Angiotensin Converting Enzyme 2) is the receptor of SARS-CoV-2 infected cells, and the infection process depends on the serine protease TMPRSS2. Blocking the interaction between S protein and ACE2 is an effective way to treat coronavirus infection.

Proteinase K

Proteinase K is a kind of high activity proteinase of subtilisin, which is used to degrade proteins in biological samples. It can be used to digest various proteins, and it can be used in a variety of molecular biology, cell biology and other related experiments, such as genomic DNA extraction, enzyme digestion and removal, cell permeability and so on.
Proteinase K is mainly used for the production of nucleic acid extraction kit, especially for nucleic acid extraction from samples of nucleic acid diagnosis and detection in vitro diagnosis (IVD) industry.

SARS-COV-2 Peptide

In view of the hot targets, the Elabscience® expert team has designed and synthesized the SARS-COV-2 (2019-nCoV) related peptide, providing comprehensive support.

Category Name Cat.No.
2019-nCoV Non-structural Protein 3C-like Proteinase Protein (His Tag)(Active) PKSR030465
Helicase Protein (His Tag) PKSR030466
NSP1 Protein (His Tag) PKSR030467
NSP2 Protein (His Tag) PKSR030468
NSP7 Protein (His Tag) PKSR030469
NSP8 Protein (His Tag) PKSR030470
NSP10 Protein (His Tag) PKSR030471
Papain-Like Protease Protein (Active) PKSR030472
Guanine-N7_meth Protein (His Tag) PKSR030473
2019-nCoV Structural Protein Spike Protein (RBD, mFc Tag)(Active) PKSR030474
Spike Protein (RBD, His Tag)(Active) PKSR030475
Spike Protein (RBD-SD1, mFc Tag)(Active) PKSR030476
Spike Protein (RBD-SD1, sHis Tag)(Active) PKSR030477
Spike Protein (RBD-SD1, Avi-His Tag)(Active) PKSR030478
S1 Protein (mFc Tag)(Active) PKSR030479
S1 Protein (Fc Tag)(Active) PKSR030480
S1 Protein (Active) PKSR030481
S1 Protein (His Tag) PKSR030482
S1 Protein (CTD, sssHis Tag) PKSR030483
Spike Protein (NTD, His Tag) PKSR030484
Nucleocapsid Protein (His Tag) PKSR030485
NP NTD domain (His Tag) PKSR030486
NP CTD domain Protein PKSR030487
Envelope Protein (His Tag) PKSR030488
S-trimer Protein (His Tag) PKSR030489
S2 Protein (Fc Tag) PKSR030491
NP (Truncated) (His Tag)(Active) PKSR030537
NP NTD domain V2(His Tag) PKSR030538
N Protein (His Tag) E-ELC-001
2019-nCoV Host Protein Human ACE-2 Protein (Fc Tag)(Active) PKSR030492
Human ACE-2 Protein (Avi-His Tag)(Active) PKSR030493
Human ACE-2 Protein (mFc Tag)(Active) PKSR030494
Human APN Protein (His Tag) PKSR030495
2019-nCoV Spike Mutant Protein Spike Protein (RBD, mFc Tag)(V367F) PKSR030523
Spike Protein (RBD,His Tag)(V367F) PKSR030524
Spike Protein (RBD, His Tag)(F342L) PKSR030526
Spike Protein (RBD, His Tag)(A435S) PKSR030528
Spike Protein (RBD, His Tag)(N354D) PKSR030529
S1 Protein (His Tag)(D614G)(Active) PKSR030531
S1 Protein, Biotinylated (Avi-His Tag)(Active) PKSR030532
Spike Protein (RBD, His Tag)(G476S)(Active) PKSR030533
Spike Protein (RBD, His Tag)(W436R)(Active) PKSR030534
Spike Protein, Biotinylated (RBD, Avi-His Tag)(Active) PKSR030535
Spike Protein, Biotinylated (RBD, Avi-His Tag)(Active) PKSR030536
S1 Protein (His Tag)(D614G)(Active) PKSR030540
S-trimer Protein (His Tag)(D614G)(Active) PKSR030541

SARS-CoV-2 Variant Antibodies

Omicron and other variant cross-reacting Antibodies*

Catalogue #Antibody NameVariant tested cross reactivity
E-AB-V1001SARS-COV-2 Spike Monoclonal Antibody(2019-nCoV)Omicron, Delta, Alpha
E-AB-V1008SARS-COV-2 Spike Monoclonal Antibody(2019-nCoV)Omicron, Delta, Alpha
E-AB-V1011SARS-COV-2 NP Monoclonal Antibody(2019-nCoV)Omicron, Delta, Alpha
E-AB-V1012SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV)Omicron, Delta, Alpha
E-AB-V1018SARS-COV-2 NP Monoclonal Antibody(2019-nCoV)Omicron, Delta, Alpha

*Antibodies binding specificity has been validated

SARS-CoV/CoV-2 (2019-nCoV) Antibodies

Since the SARS-CoV-2-Spike protein and Nucleocapsid Protein (NP) are the biomarkers of 2019-nCoV, and angiotensin convertenzyme 2 (ACE-2) is the main surface receptor to SARS-CoV-2 , it is important to fully understand the role these proteins play in SARS-CoV-2 infection. Elabsicnece® offers a variety of antibodies to investigate the mechanisms of the SARS-CoV-2 life cycle.

Molecule Cat. No. Product Name Applications
SARS-CoV-2 Spike E-AB-V1001 SARS-COV-2 Spike Monoclonal Antibody(2019-nCoV) ELISA
E-AB-V1002 SARS-COV-2 Spike Monoclonal Antibody(2019-nCoV) ELISA
E-AB-V1003 SARS-COV-2 Spike Monoclonal Antibody(2019-nCoV) IF,ELISA
E-AB-V1005 SARS-COV-2 Spike S1 Monoclonal Antibody(2019-nCoV) IF,ELISA
E-AB-V1006 SARS-COV-2 Spike RBD Polyoclonal Antibody(2019-nCoV) WB,ELISA
SARS-CoV-2-NP E-AB-V1011 SARS-COV-2 NP Monoclonal Antibody(2019-nCoV) ELISA
E-AB-V1012 SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV) ELISA
E-AB-V1013 SARS-COV-2 NP Monoclonal Antibody(2019-nCoV) WB,ELISA
E-AB-V1014 SARS-COV-2 NP Monoclonal Antibody(2019-nCoV) WB,ELISA
ACE2 E-AB-12224 ACE2 Polyclonal Antibody IHC,ELISA
E-AB-70126 ACE2 Polyclonal Antibody WB,ELISA

Tech Contact

technical@stratech.co.uk

+44 1638 782600

General Contact

info@stratech.co.uk

+44 1638 782600

SUPPORT

outstanding technical support

PRODUCT

we offer a full product guarantee

DELIVERY

we offer free delivery to UK universities and non profit organisations